M2 Presswire - FDA approves the first drug to treat irritability associated with autism, Risperdal.
M2 PRESSWIRE-9 October 2006-US FDA: FDA approves the first drug to treat irritability associated with autism, Risperdal(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:06102006 The U.S. Food and Drug Administration (FDA) today approved Risperdal (risperidone) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents.
Related Results
Antipsychotic treatment: when to measure prolactin.(Adult Psychiatry)
Patent challenge.(BARR Laboratories Inc., Janssen Pharmaceutica Products L.P….
Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Confe…
CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Confe…
WALL STREET CHOICE J&J SHARES REFLECT SLOWING PHARMA GROWTH
The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability, and include …
Read the rest of this article with a Free Trial at HighBeam Research.
